Kansas City, MO, June 23, 1999 - Quintiles Transnational Corp. announced today its intent to locate a regional pharmaceutical product development hub in Kansas City, adding 530 jobs here over the next three years.

By 2002, the company expects to employ more than 1,000 full-time Kansas City employees.

Earlier this year, Quintiles purchased, for $93 million, substantial assets of Hoechst Marion Roussel's Kansas City-based Drug Innovation and Approval organization, and opened a Kansas City contract research facility. As part of that acquisition, the company hired about 500 former HMR employees and acquired 540,000 square feet of office and lab buildings at Marion Business Park.

"After conducting a competitive analysis of several cities, we chose to grow a regional hub in Kansas City," says Dr. Dennis Gillings, Chairman & CEO, Quintiles Transnational Corp. "Kansas City offers us a central location, a highly educated workforce, and a positive business climate. In addition, the incentives offered by the state of Missouri and the city of Kansas City, Mo., were an important draw for us. We are pleased to partner with Missouri and Kansas City in this growth initiative."

Quintiles evaluated several possible expansion locations across the country before choosing Kansas City.

"This project will create many well-paying jobs in Kansas City, including many medical and scientific career professionals," says Bob Marcusse, president and CEO of the Kansas City Area Development Council. "This announcement helps support our claim that the Kansas City area is a growing hub for the life sciences industry."

Partners in the project to bring Quintiles to Kansas City include the City of Kansas City, Mo., the Economic Development Corporation for Kansas City, Mo., the Missouri Department of Economic Development, the Missouri Development Finance Board, the Missouri State Treasurer, the Hickman Mills School District, and the Kansas City Area Development Council.

"Like Ewing Kauffman's legacy, the spirit of this project and its benefits for our community are a great tribute to the Kansas City area," says Kansas City, Missouri, Mayor Kay Barnes.

"The increased presence of Quintiles here will strengthen the presence of the life sciences in the Kansas City region, and will help serve as a magnet for other businesses in the pharmaceutical, biotechnology, and medical research fields," says Missouri Governor Mel Carnahan.

"Our job in state government is to help keep Missouri's economy moving forward," says Missouri State Treasurer Bob Holden. "The Quintiles project is a tribute to what we can accomplish when we work together for the mutual benefit of all Missourians."

Quintiles Transnational Corp., www.quintiles.com, is the market leader in providing a full range of integrated product development and commercialization solutions to the pharmaceutical, biotechnology, and medical device industries. Quintiles also is a leader in the electronic data interchange and healthcare informatics industry and provides healthcare policy consulting to governments and other organizations worldwide.

Headquartered near Research Triangle Park, North Carolina, Quintiles is a Forbes Platinum 400 and Fortune 1000 company and a member of the Nasdaq-100 Index. With more than 18,000 employees worldwide and offices in 31 countries, Quintiles operates through specialized work groups dedicated to meeting customers' individual needs.

The Kansas City Area Development Council, www.smartkc.com, is the metro's umbrella economic development group, working to attract business and industry to the 14-county, bistate metro area. The Council is supported by 180 corporations and 35 communities in the metro area.